Your browser doesn't support javascript.
loading
Challenges in the Evaluation and Management of Toxicities Arising From Immune Checkpoint Inhibitor Therapy for Patients With Myeloid Malignancies.
Shallis, Rory M; Bewersdorf, Jan Philipp; Swoboda, David M; Wei, Wei; Gowda, Lohith; Prebet, Thomas; Halene, Stephanie; Pillai, Manoj M; Parker, Terri; Neparidze, Natalia; Podoltsev, Nikolai A; Seropian, Stuart; Sallman, David A; Gore, Steven D; Zeidan, Amer M.
Afiliação
  • Shallis RM; Section of Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, CT.
  • Bewersdorf JP; Section of Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, CT.
  • Swoboda DM; Department of Hematology and Oncology, H. Lee Moffitt Cancer Center, Tampa, FL.
  • Wei W; Department of Biostatistics, Yale School of Public Health, New Haven, CT.
  • Gowda L; Section of Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, CT.
  • Prebet T; Section of Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, CT.
  • Halene S; Section of Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, CT.
  • Pillai MM; Section of Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, CT.
  • Parker T; Section of Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, CT.
  • Neparidze N; Section of Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, CT.
  • Podoltsev NA; Section of Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, CT.
  • Seropian S; Section of Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, CT.
  • Sallman DA; Department of Hematology and Oncology, H. Lee Moffitt Cancer Center, Tampa, FL.
  • Gore SD; Section of Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, CT.
  • Zeidan AM; Section of Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, CT. Electronic address: amer.zeidan@yale.edu.
Clin Lymphoma Myeloma Leuk ; 21(5): e483-e487, 2021 05.
Article em En | MEDLINE | ID: mdl-33551344
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Transtornos Mieloproliferativos Limite: Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Clin Lymphoma Myeloma Leuk Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Transtornos Mieloproliferativos Limite: Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Clin Lymphoma Myeloma Leuk Ano de publicação: 2021 Tipo de documento: Article